Acadian Asset Management
CVS icon

Acadian Asset Management’s CVS Health CVS Stock Holding History

Acadian Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19M Buy
265,196
+199,496
+304% +$15.4M 0.03% 387
2025
Q4 		$5.21M Buy
65,700
+2,489
+4% +$196K 0.01% 642
2025
Q3 		$4.76M Sell
63,211
-41,591
-40% -$2.85M 0.01% 658
2025
Q2 		$7.22M Sell
104,802
-10,101
-9% -$662K 0.01% 494
2025
Q1 		$7.78M Buy
114,903
+103,281
+889% +$6.18M 0.02% 383
2024
Q4 		$521K Hold
11,622
– – ﹤0.01% 1065
2024
Q3 		$730K Sell
11,622
-36,831
-76% -$2.15M ﹤0.01% 992
2024
Q2 		$2.86M Sell
48,453
-198,452
-80% -$12.4M 0.01% 663
2024
Q1 		$19.7M Sell
246,905
-5,372
-2% -$410K 0.07% 205
2023
Q4 		$19.9M Sell
252,277
-65,588
-21% -$4.67M 0.08% 212
2023
Q3 		$22.2M Buy
317,865
+13,224
+4% +$937K 0.09% 194
2023
Q2 		$21.1M Buy
304,641
+38,412
+14% +$2.73M 0.09% 208
2023
Q1 		$19.8M Buy
266,229
+198,267
+292% +$16.6M 0.09% 220
2022
Q4 		$6.33M Sell
67,962
-41,514
-38% -$4.01M 0.03% 388
2022
Q3 		$10.4M Sell
109,476
-89,839
-45% -$8.89M 0.06% 261
2022
Q2 		$18.5M Sell
199,315
-137,925
-41% -$13.5M 0.09% 188
2022
Q1 		$34.1M Sell
337,240
-74,460
-18% -$7.82M 0.14% 161
2021
Q4 		$42.5M Buy
411,700
+41,893
+11% +$3.87M 0.16% 137
2021
Q3 		$31.4M Buy
369,807
+127,963
+53% +$10.7M 0.12% 156
2021
Q2 		$20.2M Buy
241,844
+27,136
+13% +$2.22M 0.08% 216
2021
Q1 		$16.2M Buy
214,708
+62,673
+41% +$4.57M 0.06% 249
2020
Q4 		$10.4M Buy
152,035
+89,768
+144% +$5.84M 0.04% 335
2020
Q3 		$3.64M Buy
62,267
+29,951
+93% +$1.86M 0.02% 507
2020
Q2 		$2.1M Buy
32,316
+26,763
+482% +$1.69M 0.01% 725
2020
Q1 		$330K Hold
5,553
– – ﹤0.01% 1068
2019
Q4 		$412K Hold
5,553
– – ﹤0.01% 1121
2019
Q3 		$350K Hold
5,553
– – ﹤0.01% 1180
2019
Q2 		$303K Sell
5,553
-4,208
-43% -$227K ﹤0.01% 1129
2019
Q1 		$527K Hold
9,761
– – ﹤0.01% 1086
2018
Q4 		$640K Hold
9,761
– – ﹤0.01% 850
2018
Q3 		$768K Hold
9,761
– – ﹤0.01% 792
2018
Q2 		$628K Hold
9,761
– – ﹤0.01% 841
2018
Q1 		$607K Sell
9,761
-18
-0.2% -$1.29K ﹤0.01% 818
2017
Q4 		$708K Sell
9,779
-5,595
-36% -$407K ﹤0.01% 754
2017
Q3 		$1.25M Sell
15,374
-7,209
-32% -$570K 0.01% 640
2017
Q2 		$1.82M Sell
22,583
-21,849
-49% -$1.73M 0.01% 587
2017
Q1 		$3.49M Sell
44,432
-106,337
-71% -$8.49M 0.02% 487
2016
Q4 		$11.9M Buy
150,769
+382
+0.3% +$30.9K 0.06% 259
2016
Q3 		$13.4M Sell
150,387
-1,042
-0.7% -$98.4K 0.07% 234
2016
Q2 		$14.5M Sell
151,429
-103,360
-41% -$10.3M 0.07% 211
2016
Q1 		$26.4M Sell
254,789
-499,801
-66% -$48.6M 0.13% 168
2015
Q4 		$73.8M Sell
754,590
-314,846
-29% -$30.8M 0.39% 75
2015
Q3 		$103M Buy
1,069,436
+138,670
+15% +$14.6M 0.56% 46
2015
Q2 		$97.6M Sell
930,766
-8,553
-0.9% -$874K 0.47% 51
2015
Q1 		$96.9M Buy
939,319
+348,990
+59% +$35.3M 0.45% 61
2014
Q4 		$56.9M Buy
590,329
+346,905
+143% +$30.6M 0.25% 109
2014
Q3 		$19.4M Sell
243,424
-345,154
-59% -$27.2M 0.09% 207
2014
Q2 		$44.4M Sell
588,578
-1,232,008
-68% -$93.1M 0.22% 122
2014
Q1 		$136M Buy
1,820,586
+59,428
+3% +$4.2M 0.71% 35
2013
Q4 		$126M Sell
1,761,158
-2,506,011
-59% -$161M 0.7% 36
2013
Q3 		$242M Sell
4,267,169
-27,765
-0.6% -$1.65M 1.57% 13
2013
Q2 		$246M Buy
+4,294,934
New +$249M 1.71% 7

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Acadian Asset Management's CVS Position: Q1 2026 in Review

Acadian Asset Management increased its CVS Health (CVS) stake by 304% in Q1 2026, buying an estimated $15.4M and bringing the position to 265,196 shares worth $19M. The position accounts for 0.03% of the portfolio, ranked #387.

Acadian Asset Management first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $246M in Q2 2013. 1,867 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Acadian Asset Management held 265,196 shares of CVS Health worth $19M as of Q1 2026.
  • Acadian Asset Management bought 199,496 CVS Health shares in Q1 2026, an estimated $15.4M.
  • CVS Health made up 0.03% of Acadian Asset Management's portfolio in Q1 2026, its #387 holding.
  • Acadian Asset Management first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Acadian Asset Management's CVS Health position peaked at $246M in Q2 2013.
  • 1,867 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.